Metraipolis › archive › dc_24ee72e7e76a

Apatinib — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Apatinib
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-09T16:39:27.343Z
SHA-256 of the archived text
7f46164c61173660a53e3bb9dca7d428c540dc6207276b30056d570e34bab7b3
Stable URL of this page
https://metraipolis.com/documento/dc_24ee72e7e76a

How to cite

Apatinib — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Apatinib (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_24ee72e7e76a (Metraipolis archive dc_24ee72e7e76a, sha256 7f46164c61173660a53e3bb9dca7d428c540dc6207276b30056d570e34bab7b3)
BibTeX
@misc{dc24ee72e7e76a,
  title = {Apatinib — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Apatinib},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_24ee72e7e76a; sha256 7f46164c61173660a53e3bb9dca7d428c540dc6207276b30056d570e34bab7b3},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Apatinib. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Rivoceranib, also known as apatinib, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR). It is an orally bioavailable, small molecule agent which is thought to inhibit angiogenesis in cancer cells; specifically, rivoceranib inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. This agent also mildly inhibits c-Kit and c-SRC tyrosine kinases. Apatinib was first synthesized by Advenchen Laboratories in California, US and licensed out global rights to HLB (South Korea) in 2020, and is being developed by Jiangsu Hengrui Medicine (China), LSK BioPartners (US) and HLB Life Science (South Korea). It is an investigational cancer drug undergoing clinical trials as a potential targeted treatment for metastatic gastric carcinoma, metastatic breast cancer, adenoid cystic carcinoma, and advanced hepatocellular carcinoma.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Apatinib» — https://en.wikipedia.org/wiki/Apatinib
Wikidata Q27262801: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q27262801
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Apatinib?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1366293074, consultata il 2026-11-09T16:36:55.514Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 8a92670502fe41d21c79323abe53373e4e1dc932193e56bb64e538e5a8ebc913